208 related articles for article (PubMed ID: 32443455)
1. New Treatments in Renal Cancer: The AhR Ligands.
Itkin B; Breen A; Turyanska L; Sandes EO; Bradshaw TD; Loaiza-Perez AI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443455
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI
J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
5. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
7. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
[TBL] [Abstract][Full Text] [Related]
8. Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion.
Terzuoli E; Puppo M; Rapisarda A; Uranchimeg B; Cao L; Burger AM; Ziche M; Melillo G
Cancer Res; 2010 Sep; 70(17):6837-48. PubMed ID: 20736373
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
[TBL] [Abstract][Full Text] [Related]
10. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
[TBL] [Abstract][Full Text] [Related]
11. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
[TBL] [Abstract][Full Text] [Related]
12. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling.
Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD
J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor (AhR) as a breast cancer drug target.
Baker JR; Sakoff JA; McCluskey A
Med Res Rev; 2020 May; 40(3):972-1001. PubMed ID: 31721255
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
15. Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor.
Yang T; Feng YL; Chen L; Vaziri ND; Zhao YY
Crit Rev Toxicol; 2019 May; 49(5):445-460. PubMed ID: 31433724
[TBL] [Abstract][Full Text] [Related]
16. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
[TBL] [Abstract][Full Text] [Related]
17. Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction.
Fehsel K; Schwanke K; Kappel BA; Fahimi E; Meisenzahl-Lechner E; Esser C; Hemmrich K; Haarmann-Stemmann T; Kojda G; Lange-Asschenfeldt C
J Psychopharmacol; 2022 Feb; 36(2):191-201. PubMed ID: 34979820
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma.
Zhao H; Chen L; Yang T; Feng YL; Vaziri ND; Liu BL; Liu QQ; Guo Y; Zhao YY
J Transl Med; 2019 Sep; 17(1):302. PubMed ID: 31488157
[TBL] [Abstract][Full Text] [Related]
19. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
[TBL] [Abstract][Full Text] [Related]
20. Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies.
Leclerc D; Staats Pires AC; Guillemin GJ; Gilot D
Curr Opin Immunol; 2021 Jun; 70():15-26. PubMed ID: 33429228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]